SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A
http://www.w3.org/2000/01/rdf-schema#comment
"WBP2 expression correlates with the response of HER2-positive breast cancer to trastuzumab-based neoadjuvant chemotherapy."
xsd:string
http://purl.uniprot.org/uniprot/#_AEF900AE8E2C01BA36E6B82B293DEA6A8101D69D41AE26845FFCB11BD9B290653D54A816FEFCE41B34EE22E6B1CA74B6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A
http://purl.uniprot.org/uniprot/L0R5E7
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A
http://purl.uniprot.org/uniprot/#_L0R5E7-mappedCitation-30593516
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D14E03AB4C654D7C055E53CB4BFA8E3D192D0A4109E8C6D76E06EE619C76B2BE97C08547B4BFBCEFFA2B75F6F9AB2E2A